Cellebrite DI (CLBT) Receivables (2020 - 2025)

Cellebrite DI (CLBT) has reported Receivables for 6 consecutive years, with $183.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Receivables rose 12.12% year-over-year to $183.5 million; the TTM figure through Dec 2025 stood at $183.5 million (up 12.12% YoY), while the FY2025 annual figure was $183.5 million, up 12.12% from the prior year.
• Receivables came in at $183.5 million for Q4 2025 at Cellebrite DI, up from $104.2 million in the prior quarter.
• The five-year high for Receivables was $183.5 million in Q4 2025, with the low at $67.5 million in Q2 2022.
• Average Receivables over 5 years is $104.6 million, with a median of $89.5 million recorded in 2023.
• Across the five-year window, Receivables plunged 44.15% in 2023 and soared 82.87% in 2024, its largest moves.
• Year by year, Receivables stood at $139.8 million in 2021, then gained by 14.69% to $160.3 million in 2022, then slumped by 44.15% to $89.5 million in 2023, then surged by 82.87% to $163.7 million in 2024, then advanced by 12.12% to $183.5 million in 2025.
• According to Business Quant data, Receivables over the past three periods registered $183.5 million, $104.2 million, and $93.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.